CA2431493A1 - Aminoacyl arnt synthetases - Google Patents
Aminoacyl arnt synthetases Download PDFInfo
- Publication number
- CA2431493A1 CA2431493A1 CA002431493A CA2431493A CA2431493A1 CA 2431493 A1 CA2431493 A1 CA 2431493A1 CA 002431493 A CA002431493 A CA 002431493A CA 2431493 A CA2431493 A CA 2431493A CA 2431493 A1 CA2431493 A1 CA 2431493A1
- Authority
- CA
- Canada
- Prior art keywords
- polynucleotide
- polypeptide
- sequence
- atrs
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Microbiology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
L'invention concerne des aminoacyl ARNt synthétases (ATRS) humaines et des polynucléotides qui identifient des ATRS et codent pour ces derniers. L'invention porte également sur des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes et des antagonistes. De plus, l'invention concerne des méthodes de diagnostic, de traitement et de prévention de troubles associés à une expression aberrante des ATRS.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25596300P | 2000-12-15 | 2000-12-15 | |
US60/255,963 | 2000-12-15 | ||
PCT/US2001/048575 WO2002059323A2 (fr) | 2000-12-15 | 2001-12-13 | Aminoacyl arnt synthetases |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2431493A1 true CA2431493A1 (fr) | 2002-08-01 |
Family
ID=22970573
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002431493A Abandoned CA2431493A1 (fr) | 2000-12-15 | 2001-12-13 | Aminoacyl arnt synthetases |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1349939A2 (fr) |
JP (1) | JP2004537270A (fr) |
CA (1) | CA2431493A1 (fr) |
WO (1) | WO2002059323A2 (fr) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102105164A (zh) | 2008-06-11 | 2011-06-22 | Atyr医药公司 | 酪氨酰-trna合成酶多肽的血小板生成活性 |
US8404471B2 (en) | 2008-06-26 | 2013-03-26 | Atyr Pharma, Inc. | Compositions and methods comprising glycyl-tRNA synthetases having non-canonical biological activities |
WO2010099477A2 (fr) | 2009-02-27 | 2010-09-02 | Atyr Pharma, Inc. | Motifs structuraux de polypeptides associés à une activité de signalisation cellulaire |
ES2742251T3 (es) | 2009-03-16 | 2020-02-13 | Pangu Biopharma Ltd | Composiciones y procedimientos que comprenden variantes de splicing de histidil-tarn sintetasa que tienen actividades biológicas no canónicas |
CA2757289A1 (fr) | 2009-03-31 | 2010-10-21 | Atyr Pharma, Inc. | Compositions et procedes impliquant des aspartyl-arnt synthetases presentant des activites biologiques non canoniques |
US9127268B2 (en) | 2009-12-11 | 2015-09-08 | Atyr Pharma, Inc. | Aminoacyl tRNA synthetases for modulating inflammation |
WO2011072266A2 (fr) * | 2009-12-11 | 2011-06-16 | Atyr Pharma, Inc. | Aminoacyl-arnt synthétases destinées à moduler l'hématopoïèse |
US8828395B2 (en) | 2009-12-11 | 2014-09-09 | Atyr Pharma, Inc. | Antibodies that bind tyrosyl-tRNA synthetases |
AU2011248625B2 (en) | 2010-04-26 | 2017-01-05 | Pangu Biopharma Limited | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-tRNA synthetase |
JP6294074B2 (ja) | 2010-04-27 | 2018-03-14 | エータイアー ファーマ, インコーポレイテッド | イソロイシルtRNA合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見 |
CA2797259C (fr) | 2010-04-27 | 2020-09-29 | Atyr Pharma, Inc. | Decouverte innovante de compositions therapeutiques, de diagnostic et d'anticorps se rapportant a des fragments proteiques de threonyl arnt synthetases |
EP2563911B1 (fr) | 2010-04-28 | 2021-07-21 | aTyr Pharma, Inc. | Compositions thérapeutiques, diagnostiques et d'anticorps à base de fragments de protéines d'aminoacyl-arnt synthétases |
WO2011139907A2 (fr) | 2010-04-29 | 2011-11-10 | Atyr Pharma, Inc. | Découverte innovatrice de compositions thérapeutiques, diagnostiques, et d'anticorps associées aux fragments protéiques des valyle arnt synthésases |
WO2011139854A2 (fr) | 2010-04-29 | 2011-11-10 | Atyr Pharma, Inc. | Découverte innovante de compositions thérapeutiques, diagnostiques et à based'anticorps associées à des fragments protéiques d'asparaginyl-arnt-synthétases |
ES2623805T3 (es) | 2010-05-03 | 2017-07-12 | Atyr Pharma, Inc. | Descubrimiento innovador de composiciones terapéuticas, de diagnóstico y de anticuerpos relacionadas con fragmentos de proteínas de fenilalanil-alfa-ARNt sintetasas |
WO2011139988A2 (fr) | 2010-05-03 | 2011-11-10 | Atyr Pharma, Inc. | Découverte innovante de compositions thérapeutiques, de diagnostic et d'anticorps liées à des fragments protéiques de séryle-arnt synthétases |
WO2011139986A2 (fr) | 2010-05-03 | 2011-11-10 | Atyr Pharma, Inc. | Découverte innovante de compositions thérapeutiques, de diagnostic et d'anticorps liées à des fragments protéiques d'arginyle-arnt synthétases |
WO2011140135A2 (fr) | 2010-05-03 | 2011-11-10 | Atyr Pharma, Inc. | Découverte innovante de compositions thérapeutiques, diagnostiques et à base d'anticorps liées des fragments protéiques de méthionyl-arnt-synthétases |
EP2566499B1 (fr) | 2010-05-04 | 2017-01-25 | aTyr Pharma, Inc. | Découverte innovante de compositions thérapeutiques, diagnostiques et à base d'anticorps liées à des fragments protéiques de complexe multi-arnt synthétase p38 |
CA2798301C (fr) | 2010-05-04 | 2020-09-15 | Atyr Pharma, Inc. | Decouverte innovante de compositions therapeutiques, diagnostiques et a base d'anticorps liees a des fragments proteiques de glutamyl-prolyl-arnt-synthetases |
US8945541B2 (en) | 2010-05-14 | 2015-02-03 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-tRNA synthetases |
CN103096914B (zh) | 2010-05-17 | 2015-08-12 | Atyr医药公司 | 与亮氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现 |
JP6046607B2 (ja) | 2010-05-27 | 2016-12-21 | エータイアー ファーマ, インコーポレイテッド | グルタミニルtRNA合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見 |
JP5906237B2 (ja) * | 2010-06-01 | 2016-04-20 | エータイアー ファーマ, インコーポレイテッド | リジルtRNA合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見 |
US8999321B2 (en) | 2010-07-12 | 2015-04-07 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases |
WO2012021249A2 (fr) | 2010-07-12 | 2012-02-16 | Atyr Pharma, Inc. | DÉCOUVERTE INNOVANTE DE COMPOSITIONS THÉRAPEUTIQUES, DIAGNOSTIQUES ET D'ANTICORPS SE RAPPORTANT À DES FRAGMENTS PROTÉIQUES D' HISTIDYLE-ARNt SYNTHÉTASES |
WO2012009289A2 (fr) * | 2010-07-12 | 2012-01-19 | Atyr Pharma, Inc. | Découverte innovante de compositions thérapeutiques, diagnostiques et d'anticorps relatives à des fragments protéiques d'aspartyl-arnt synthétases |
CA2804416C (fr) | 2010-07-12 | 2020-04-28 | Atyr Pharma, Inc. | Decouverte innovante de compositions therapeutiques, de diagnostic et d'anticorps se rapportant a des fragments proteiques de glycyl-arnt synthetases |
CN103108650A (zh) | 2010-08-25 | 2013-05-15 | Atyr医药公司 | 与酪氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现 |
ES2645019T3 (es) | 2010-10-06 | 2017-12-01 | Atyr Pharma, Inc. | Descubrimiento innovador de composiciones terapéuticas, de diagnóstico y de anticuerpos relacionadas con fragmentos de proteínas de triptofanil-ARNt sintetasas |
US9714419B2 (en) | 2011-08-09 | 2017-07-25 | Atyr Pharma, Inc. | PEGylated tyrosyl-tRNA synthetase polypeptides |
US9822353B2 (en) | 2011-12-06 | 2017-11-21 | Atyr Pharma, Inc. | PEGylated aspartyl-tRNA synthetase polypeptides |
WO2013086216A1 (fr) | 2011-12-06 | 2013-06-13 | Atyr Pharma, Inc. | Aspartyl-arnt synthétases améliorées |
JP6169608B2 (ja) | 2011-12-29 | 2017-07-26 | エータイアー ファーマ, インコーポレイテッド | アスパルチルtRNAシンテターゼ−Fcコンジュゲート |
AU2013221317B2 (en) | 2012-02-16 | 2017-07-06 | Pangu Biopharma Limited | Histidyl-tRNA synthetases for treating autoimmune and inflammatory diseases |
DK3460054T3 (da) | 2013-03-15 | 2021-01-18 | Atyr Pharma Inc | Histidyl-tRNA-syntetase-Fc-konjugater |
AU2018256435A1 (en) | 2017-04-20 | 2019-11-07 | Atyr Pharma, Inc. | Compositions and methods for treating lung inflammation |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0909818A1 (fr) * | 1997-10-17 | 1999-04-21 | Smithkline Beecham Corporation | Valyl tRNA synthetase (EC 6.1.1.9) de Streptococcus pneumoniae |
AU2001263404A1 (en) * | 2000-05-25 | 2001-12-03 | Incyte Genomics, Inc. | Aminoacyl trna synthetases |
-
2001
- 2001-12-13 EP EP01994254A patent/EP1349939A2/fr not_active Withdrawn
- 2001-12-13 WO PCT/US2001/048575 patent/WO2002059323A2/fr not_active Application Discontinuation
- 2001-12-13 JP JP2002559808A patent/JP2004537270A/ja active Pending
- 2001-12-13 CA CA002431493A patent/CA2431493A1/fr not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2004537270A (ja) | 2004-12-16 |
WO2002059323A2 (fr) | 2002-08-01 |
WO2002059323A3 (fr) | 2003-07-24 |
EP1349939A2 (fr) | 2003-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20040048290A1 (en) | Aminoacyl trna synthetases | |
US20040018505A1 (en) | Aminoacyl trna synthetases | |
CA2431493A1 (fr) | Aminoacyl arnt synthetases | |
CA2408315A1 (fr) | Aminoacyl-arnt synthetases | |
US20050227277A1 (en) | Apoptosis proteins | |
EP1179065A2 (fr) | Molecules completes exprimees dans des tissus humains | |
US20020160950A1 (en) | Cytochrome P450 variant | |
EP1299546A2 (fr) | Aminoacyl arnt synthetases | |
WO2002048362A2 (fr) | Proteines associees a l'embryogenese | |
WO2002046413A2 (fr) | Molecules pour la detection et le traitement de maladies | |
WO2001004308A1 (fr) | Proteines humaines de domaine lim | |
WO2000073334A2 (fr) | Tri de nexines | |
CA2425767A1 (fr) | Lipocalines | |
CA2402747A1 (fr) | Molecules associees a la proteine g | |
US20040033583A1 (en) | Isomerases | |
EP1265918A1 (fr) | Proteines de reponse immunitaire humaines | |
EP1192250A2 (fr) | Proteines du metabolisme de l'arn | |
WO2002064792A2 (fr) | Molecules utiles pour detecter et traiter des maladies | |
EP1242590A2 (fr) | Lyases humaines et proteines associees | |
CA2381338A1 (fr) | Lyases humaines | |
US20040023251A1 (en) | Cell cycle proteins and mitosis-associated molecules | |
US20030208040A1 (en) | G-protein associated molecules | |
EP1477564A2 (fr) | Synthetases humaines | |
CA2415077A1 (fr) | Proteines du cycle cellulaire et molecules associees a la mitose | |
EP1196569A2 (fr) | Proteines de transfert d'electrons |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |